Document is current
Any future updates will be listed below
-
Authors
Makker, Vicky
Green, Angela K.
Wenham, Robert M.
Mutch, David
Davidson, Brittany
Miller, David Scott
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 7 August 2017
Accepted: 13 November 2017
First Online: 2 December 2017
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Dr. Robert M. Wenham has received study grant support from Merck and honoraria from Tesaro, Genentech, Clovis, and Jansen. Dr. Vicky Makker has received an honorarium from Eisai, as well as study support from Lilly, AstraZeneca, and Kryopharm. Dr. David Mutch has served as speaker for Clovis. Dr. David Miller has received grant funding from Tracon, Arno, Tesaro, Aprea, AstraZeneca, Janssen, Aeterna Zentaris, and Millenium; honorariums from Clovis, Eisai, Tesaro, AstraZeneca, Gaurdant, Genentech, and Alexion; and speaks for Genentech and Clovis. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
